SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-002291
Filing Date
2012-01-11
Accepted
2012-01-11 18:03:10
Documents
2
Period of Report
2011-12-20

Document Format Files

Seq Description Document Type Size
1 DAVIS 122011 FORM 4/A rrd329610.html 4/A  
1 DAVIS 122011 FORM 4/A rrd329610.xml 4/A 4072
2 DAVIS POA rrd295247_333955.htm EX-24. 2915
  Complete submission text file 0001181431-12-002291.txt   8488
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23155 | Film No.: 12522878